An optimized reverse-phase high performance liquid chromatographic method for evaluating percutaneous absorption of glucosamine hydrochloride

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 2, 2006, Pages 385-392

  Tekko, Ismaiel A ^a   Bonner, Michael C ^a   Williams, Adrian C ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Derivatisation; Glucosamine hydrochloride; Percutaneous absorption; Phenylisothiocyanate; Reverse phase high performance liquid chromatography; Skin

Indexed keywords

ACETIC ACID; GALACTOSAMINE; GLUCOSAMINE; METHANOL; PHENYL ISOTHIOCYANATE; THIOCARBAMIC ACID DERIVATIVE; WATER;

ACCURACY; ACIDITY; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DIODE; DRUG ADSORPTION; DRUG PENETRATION; DRUG STABILITY; ELUTION; EPIDERMIS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; SKIN PERMEABILITY; STANDARD; TEMPERATURE DEPENDENCE;

ADMINISTRATION, CUTANEOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCOSAMINE; HUMANS; ISOTHIOCYANATES; PERMEABILITY; REPRODUCIBILITY OF RESULTS; SKIN ABSORPTION; TEMPERATURE; TIME FACTORS;

EID: 33645972318     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.11.044     Document Type: Article

References (22)

1. Hawker G. Curr. Opin. Rheumatol. 9 (1997) 90-94
2. Vidal y Plana R.R., Bizzari D., and Rovati A.L. Pharmacol. Res. Commun. 10 (1978) 557-569
3. Bassleer C., Henrotin Y., and Franchimont P. Int. J. Tissue React. 14 (1992) 231-241
4. Fenton J.I., Chlebek-Brown K.A., Peters T.L., Caron J.P., and Orth M.W. Osteoarthritis and cartilage 8 (2000) 444-451
5. Tamai Y., Miyatake K., Okamoto Y., Takamori Y., Sakamoto H., and Minami S. Carbohydr. Polym. 48 (2001) 369-378
6. Aghazadeh-Habashi A., Sattari S., Pasutto F., and Jamali F. J. Pharm. Pharmaceut. Sci. 5 (2002) 181-184
7. Barry B.W. Dermatological Formulations: Percutaneous Absorption (1983), Marcel Dekker, New York
8. Tekko I.A., Bonner M.C., and Williams A.C. AAPS Annual Meeting and Exposition. Salt Lake City, USA, October (2003)
9. Williams A.C. Transdermal and Topical Drug Delivery (2003), Pharmaceutical Press, London
10. El-Saharty Y.S., and Abdel Bary A. Anal. Chim. Acta 462 (2002) 125-131
11. Aghazadeh-Habashi A., Sattari S., Pasutto F., and Jamali F. J. Pharm. Sci. 5 (2002) 176-180
12. Liang Z., Leslie J., Adebowale A., Ashraf M., and Eddington N.D. J. Pharm. Biomed. Anal. 20 (1999) 807-814
13. Kanwischer M., Kim S.Y., and Kim J.S. Drug Dev. Ind. Pharm. 1 (2005) 91-97
14. International Conference on Harmonization (ICH), Validation of Analytical Methods: Methodology, ICH Q 2 B, 1996.
15. Chun I.K., and Chein Y.W. J. Pharm. Sci. 82 (1993) 373-378
16. Kligman A.M., and Christophers E. Arch. Dermatol. 88 (1963) 70-73
17. Davey J.F., and Ersser R.S. J. Chromatogr. 528 (1990) 9-23
18. Lawrence E.L., and Holcenberg J.H. J. Chromatogr 377 (1986) 155-163
19. Tekko I.A., Bonner M.C., and Williams A.C. Proceedings of the Ninth International Conference, Perspectives in Percutaneous Penetration. La Grande Motte, France, April (2004)
20. Cross S.E., and Roberts M.S. J. Pharm. Sci. 84 (1995) 584-592
21. Wilschut A., ten Berge W.F., Robinson P.J., and McKone T.E. Chemosphere 30 (1995) 1275-1296
22. Moss G.P., Dearden J.C., Patel H., and Cronin M.T.D. Toxicol. In Vitro 16 (2002) 229-317